What is the ROCE (Return on Capital Employed) of Genovis this year?
The ROCE of Genovis is 0.29 undefined this year.
Genovis ROCE 2024
Genovis ROCE
0.29
Ticker
GENO.ST
ISIN
SE0002485979
WKN
A0Q4ER
In 2024, Genovis's return on capital employed (ROCE) was 0.29, a 161.47% increase from the 0.11 ROCE in the previous year.
Genovis Aktienanalyse
What does Genovis do?
Genovis AB is a Swedish company that offers biotechnology solutions for drug research and diagnostic industries. The company was founded in Lund, Sweden in 1999 and currently employs over 30 employees. Genovis began with the development of enzymes for protein-based therapeutics, but over time expanded its business to include enzymes for improved analysis methods in mass spectrometry. Genovis has become a leading provider of innovative enzyme solutions and proteomics tools for biomedical research. The company's business model is based on providing specially developed enzymes and proteomics tools to companies in drug research and diagnostic industries. Genovis has two main business areas: marketing enzymes and providing peptide synthesis services. The first business area is the marketing of enzymes for the separation of glycosylated proteins in mass spectrometry. The company develops and produces these enzymes for various applications such as Alzheimer's research, cancer research, and infectious diseases. Genovis is also an important provider of enzymes for the investigation of antibody-drug conjugates used in novel therapeutic approaches. The second business area is providing peptide synthesis services. The company also has a diversified biotechnology infrastructure and offers analysis and synthesis services for peptides in various fields, such as immunotherapy and diagnostics. Genovis' product portfolio includes a variety of enzymes that have broad application in drug research and diagnostic industries. This includes enzymes for antibody proteolysis, enzymes for the synthesis of glycoconjugates, and enzymes for conjugated protein analysis. In addition, the company also offers specialized kits for protein analysis. Genovis kits always include all necessary components such as proteases, buffer systems, and instructions to conduct the offered experiments. In conclusion, Genovis is a leading company in the biotechnology industry that offers innovative enzyme solutions and proteomics tools for a variety of applications in medical research and diagnostics. With its diversified biotechnology infrastructure and dedicated employees, the company can meet the growing needs of its customers in the science and industry sectors and has become a key partner in the healthcare industry. Genovis ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Genovis's Return on Capital Employed (ROCE)
Genovis's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Genovis's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Genovis's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Genovis’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Genovis stock
How has the ROCE (Return on Capital Employed) of Genovis developed compared to the previous year?
The ROCE of Genovis has increased by 161.47% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Genovis?
A high Return on Capital Employed (ROCE) indicates that Genovis has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Genovis?
A low ROCE (Return on Capital Employed) can indicate that Genovis has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Genovis impact the company?
An increase in the ROCE of Genovis can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Genovis affect the company?
A decrease in ROCE of Genovis can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Genovis?
Some factors that can affect Genovis's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Genovis so important for investors?
The ROCE of Genovis is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Genovis take to improve the ROCE?
To improve the ROCE, Genovis can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Genovis pay?
Over the past 12 months, Genovis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genovis is expected to pay a dividend of 0 SEK.
What is the dividend yield of Genovis?
The current dividend yield of Genovis is .
When does Genovis pay dividends?
Genovis pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genovis?
Genovis paid dividends every year for the past 0 years.
What is the dividend of Genovis?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genovis located?
Genovis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genovis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genovis from 11/1/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.
When did Genovis pay the last dividend?
The last dividend was paid out on 11/1/2024.
What was the dividend of Genovis in the year 2023?
In the year 2023, Genovis distributed 0 SEK as dividends.
In which currency does Genovis pay out the dividend?
The dividends of Genovis are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Genovis
Our stock analysis for Genovis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genovis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
